I assuming the up to $124m is over maybe 5 years .expect a bit paid on for each clinical trial and some for regulatory approval in US and EU and maybe China. And A bit for sales launch and a bit more for sales of say $500m and $1b and $2b and maybe even a bit more for $5b sales. So not going to have much affects on bottom line.
Anybody want to haveing a guess what the company will make in royalties IF $2b peak sales is true. (the bcl Xl reviews article ab posted on another tread suggest could be competitors too. )
I assuming the up to $124m is over maybe 5 years .expect a bit...
-
- There are more pages in this discussion • 10 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
